AI and smartphones join the fight against multiple sclerosis

NCT ID NCT06526364

Recruiting now Knowledge-focused Sponsor: University Hospital, Basel, Switzerland Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated Jun 12, 2026 · Updated 26 times

Summary

This study aims to better understand multiple sclerosis (MS) by using artificial intelligence and digital health tools. Researchers will follow 100 adults with MS, collecting medical images, blood samples, and smartphone data to find patterns that predict disease progression. No new treatments are tested; the goal is to improve monitoring and future care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB)
RECRUITING

Basel, 4031, Switzerland

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

The condition(s) this trial relates to.

chronic progressive multiple sclerosis multiple sclerosis relapsing-remitting multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE SCLEROSIS MULTIPLE SCLEROSIS, PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS, RELAPSING-REMITTING MULTIPLE SCLEROSIS, SECONDARY PROGRESSIVE